target
stringclasses 5
values | description
stringlengths 2
1.81k
⌀ | description_cln
stringlengths 2
1.77k
⌀ |
|---|---|---|
CONCLUSIONS | Classic acupuncture and YNSA are similarly effective in the prophylaxis and treatment of migraine headache and may be considered as alternatives to pharmacotherapy . | Classic acupuncture and YNSA are similarly effective in the prophylaxis and treatment of migraine headache and may be considered as alternatives to pharmacotherapy. |
OBJECTIVE | To determine the clinical sensitivity , specificity , negative predictive value , and positive predictive value of a rapid point-of-care diagnostic test to detect elevated matrix metalloproteinase 9 levels ( InflammaDry ) . | To determine the clinical sensitivity, specificity, negative predictive value, and positive predictive value of a rapid point-of-care diagnostic test to detect elevated matrix metalloproteinase 9 levels (InflammaDry). |
METHODS | In a prospective , sequential , masked , multicenter clinical trial , InflammaDry was performed on 206 patients : 143 patients with clinical signs and symptoms of dysfunctional tear syndrome ( dry eyes ) and 63 healthy individuals serving as controls . | In a prospective, sequential, masked, multicenter clinical trial, InflammaDry was performed on 206 patients : 143 patients with clinical signs and symptoms of dysfunctional tear syndrome (dry eyes) and 63 healthy individuals serving as controls. |
METHODS | Participants were assessed as healthy controls or for a clinical diagnosis of dry eye using the Ocular Surface Disease Index , Schirmer tear test , tear breakup time , and keratoconjunctival staining . | Participants were assessed as healthy controls or for a clinical diagnosis of dry eye using the Ocular Surface Disease Index, Schirmer tear test, tear breakup time, and keratoconjunctival staining. |
METHODS | The sensitivity and specificity of InflammaDry were compared with clinical assessment . | The sensitivity and specificity of InflammaDry were compared with clinical assessment. |
RESULTS | InflammaDry showed sensitivity of 85 % ( in 121 of 143 patients ) , specificity of 94 % ( 59 of 63 ) , negative predictive value of 73 % ( 59 of 81 ) , and positive predictive value of 97 % ( 121 of 125 ) . | InflammaDry showed sensitivity of 85 % (in 121 of 143 patients), specificity of 94 % (59 of 63), negative predictive value of 73 % (59 of 81), and positive predictive value of 97 % (121 of 125). |
CONCLUSIONS | Compared with clinical assessment , InflammaDry is sensitive and specific in diagnosing dry eye . | Compared with clinical assessment, InflammaDry is sensitive and specific in diagnosing dry eye. |
CONCLUSIONS | Dry eye is often underdiagnosed resulting from poor communication between the clinical assessment of dry eye severity between clinicians and patients . | Dry eye is often underdiagnosed resulting from poor communication between the clinical assessment of dry eye severity between clinicians and patients. |
CONCLUSIONS | This often leads to a lack of effective treatment . | This often leads to a lack of effective treatment. |
CONCLUSIONS | Matrix metalloproteinase 9 is an inflammatory biomarker that has been shown to be elevated in the tears of patients with dry eyes . | Matrix metalloproteinase 9 is an inflammatory biomarker that has been shown to be elevated in the tears of patients with dry eyes. |
CONCLUSIONS | The ability to accurately detect elevated matrix metalloproteinase 9 levels may lead to earlier diagnosis , more appropriate treatment , and better management of ocular surface disease . | The ability to accurately detect elevated matrix metalloproteinase 9 levels may lead to earlier diagnosis, more appropriate treatment, and better management of ocular surface disease. |
CONCLUSIONS | Preoperative and perioperative management of inflammation related to dry eyes may reduce dry eyes that develop after laser in situ keratomileusis , improve wound healing , and reduce flap complications . | Preoperative and perioperative management of inflammation related to dry eyes may reduce dry eyes that develop after laser in situ keratomileusis, improve wound healing, and reduce flap complications. |
CONCLUSIONS | Recognition of inflammation may allow for targeted perioperative therapeutic management of care for patients who undergo cataract and refractive surgery and improve outcomes . | Recognition of inflammation may allow for targeted perioperative therapeutic management of care for patients who undergo cataract and refractive surgery and improve outcomes. |
BACKGROUND | clinicaltrials.gov Identifier : NCT01313351 . | clinicaltrials. gov Identifier : NCT01313351. |
OBJECTIVE | To assess the effects of ambulation during the first stage of labor on the duration of labor and other maternal and infant outcomes . | To assess the effects of ambulation during the first stage of labor on the duration of labor and other maternal and infant outcomes. |
METHODS | A prospective randomized trial conducted from 1stNovember2008 to 31stMarch2009 at the department of obstetrics and gynecology , CHU Farhat Hached , Sousse , Tunisia . | A prospective randomized trial conducted from 1stNovember2008 to 31stMarch2009 at the department of obstetrics and gynecology, CHU Farhat Hached, Sousse, Tunisia. |
METHODS | Two hundred mothers with uncomplicated term pregnancies were randomly assigned to one of two groups : first group ( 100 parturients ) authorized to ambulate until 6cm of cervical dilation and a second group ( 100 parturients ) confined to bed in dorsal or lateral recumbence . | Two hundred mothers with uncomplicated term pregnancies were randomly assigned to one of two groups : first group (100 parturients) authorized to ambulate until 6cm of cervical dilation and a second group (100 parturients) confined to bed in dorsal or lateral recumbence. |
RESULTS | Upright position reduces significantly ( for about 34 % ) the duration of the first stage of labor ( P < 0.0001 ) , the pain intensity , the oxytocin consumption ( P = 0.001 ) , the rate of delivery by cesarean section and of instrumental deliveries . | Upright position reduces significantly (for about 34 %) the duration of the first stage of labor (P < 0. 0001), the pain intensity, the oxytocin consumption (P = 0. 001), the rate of delivery by cesarean section and of instrumental deliveries. |
RESULTS | Upright position leads also to a net improvement of the maternal outcome ( 7 % side effects versus 13 % ) and the fetal outcome ( net improvement of the Apgar 's score at first and fifth minute , and reduction of a factor5 of the rate of transfer to the neonatology clinical care unit . | Upright position leads also to a net improvement of the maternal outcome (7 % side effects versus 13 %) and the fetal outcome (net improvement of the Apgar 's score at first and fifth minute, and reduction of a factor5 of the rate of transfer to the neonatology clinical care unit. |
CONCLUSIONS | Our study allowed to confirm the benefits of ambulation on labor progress as well as on the maternal comfort and the maternofetal outcome . | Our study allowed to confirm the benefits of ambulation on labor progress as well as on the maternal comfort and the maternofetal outcome. |
OBJECTIVE | The aim of this trial is to evaluate the role Lactobacillus paracasei in Bell 's stage 2 in order to prevent the clinical progression to stage 3 . | The aim of this trial is to evaluate the role Lactobacillus paracasei in Bell 's stage 2 in order to prevent the clinical progression to stage 3. |
METHODS | A prospective study was approved and started in December 2008 . | A prospective study was approved and started in December 2008. |
METHODS | Patients were infants with birth weight 600 to 1500 g. | Patients were infants with birth weight 600 to 1500 g. |
METHODS | One group received probiotic supplementation ( L. paracasei susp.paracasei F-19 ) and the control group received only standard medical treatment . | One group received probiotic supplementation (L. paracasei susp. paracasei F-19) and the control group received only standard medical treatment. |
METHODS | The primary outcome was the progression to stage 3 as defined by Bell 's modified criteria . | The primary outcome was the progression to stage 3 as defined by Bell 's modified criteria. |
METHODS | Inclusion and exclusion criteria were created and discussed with parents before treatment . | Inclusion and exclusion criteria were created and discussed with parents before treatment. |
RESULTS | Thirty-two patients ( stage 2 NEC ) were considered eligible for the study . | Thirty-two patients (stage 2 NEC) were considered eligible for the study. |
RESULTS | Group A : 18 patients and Group B : 14 patients . | Group A : 18 patients and Group B : 14 patients. |
RESULTS | Three patients in group A and six patients in group B had a clinical history of Bell 's stage 3 NEC ( P < 0.05 ) ; oral supplementation of L. paracasei reduced the clinical progression of NEC . | Three patients in group A and six patients in group B had a clinical history of Bell 's stage 3 NEC (P < 0. 05) ; oral supplementation of L. paracasei reduced the clinical progression of NEC. |
RESULTS | It was considered that an improvement in intestinal motility might have contributed to this result . | It was considered that an improvement in intestinal motility might have contributed to this result. |
CONCLUSIONS | The use of Lactobacillus paracasei subsp . | The use of Lactobacillus paracasei subsp. |
CONCLUSIONS | paracasei F-19 is safe ; the low progression rate to stage 3 NEC suggests that the use of this probiotic in stage 2 NEC could be a valuable therapeutic option . | paracasei F-19 is safe ; the low progression rate to stage 3 NEC suggests that the use of this probiotic in stage 2 NEC could be a valuable therapeutic option. |
BACKGROUND | Type II diabetes is often associated with high blood pressure , elevated sympathetic activity , and high plasma insulin levels . | Type II diabetes is often associated with high blood pressure, elevated sympathetic activity, and high plasma insulin levels. |
BACKGROUND | Hypoglycemic agents may negatively interfere with blood pressure control , sympathetic activity , and plasma insulin level ; therefore the choice of treatment in type II diabetes may be crucial . | Hypoglycemic agents may negatively interfere with blood pressure control, sympathetic activity, and plasma insulin level ; therefore the choice of treatment in type II diabetes may be crucial. |
BACKGROUND | We aimed to compare the effects of two hypoglycemic drugs on blood glucose , blood pressure , sympathetic activity , and insulin levels in type II diabetic and hypertensive patients . | We aimed to compare the effects of two hypoglycemic drugs on blood glucose, blood pressure, sympathetic activity, and insulin levels in type II diabetic and hypertensive patients. |
METHODS | Forty-eight ( 24M , 24F ) type II diabetic , hypertensive , and hyperlipidemic subjects were enrolled and treated for 4 weeks with an ACE inhibitor ( Cilazapril ) and a statin ( Simvastatin ) . | Forty-eight (24M, 24F) type II diabetic, hypertensive, and hyperlipidemic subjects were enrolled and treated for 4 weeks with an ACE inhibitor (Cilazapril) and a statin (Simvastatin). |
METHODS | They were then randomized into two groups to receive a thiazolidinedione ( Rosiglitazone ; ROS ) or a sulfonylurea ( Glibenclamide ; GLB ) for 8 weeks . | They were then randomized into two groups to receive a thiazolidinedione (Rosiglitazone ; ROS) or a sulfonylurea (Glibenclamide ; GLB) for 8 weeks. |
METHODS | Blood biochemistry , blood pressure , plasma insulin , endothelial function , and sympathetic skin activity were measured before and after treatment . | Blood biochemistry, blood pressure, plasma insulin, endothelial function, and sympathetic skin activity were measured before and after treatment. |
RESULTS | A significant drop in systolic and diastolic blood pressure by 6.1 + / - 4.1 mm Hg and 4.2 + / - 1.9 mm Hg respectively ; a reduction in plasma insulin concentration by 4.3 + / - 1.9 mU/L and a decline in skin sympathetic activity were observed in the group receiving ROS . | A significant drop in systolic and diastolic blood pressure by 6. 1 + / - 4. 1 mm Hg and 4. 2 + / - 1. 9 mm Hg respectively ; a reduction in plasma insulin concentration by 4. 3 + / - 1. 9 mU/L and a decline in skin sympathetic activity were observed in the group receiving ROS. |
RESULTS | The GLB group showed an increase in systolic blood pressure by 3.1 + / - 2.5 mm Hg , no change in diastolic blood pressure , significant elevation in plasma insulin concentration by 2.3 + / - 1.4 mu/L , and augmentation of sympathetic activity . | The GLB group showed an increase in systolic blood pressure by 3. 1 + / - 2. 5 mm Hg, no change in diastolic blood pressure, significant elevation in plasma insulin concentration by 2. 3 + / - 1. 4 mu/L, and augmentation of sympathetic activity. |
RESULTS | No significant changes in endothelial function were observed in either group . | No significant changes in endothelial function were observed in either group. |
CONCLUSIONS | Rosiglitazone improved both plasma glucose and blood pressure levels , probably by attenuation of hyperinsulinemia and sympathetic activity , while Glibenclamide worsened blood pressure control possibly by elevation of insulin levels and activation of the sympathetic system . | Rosiglitazone improved both plasma glucose and blood pressure levels, probably by attenuation of hyperinsulinemia and sympathetic activity, while Glibenclamide worsened blood pressure control possibly by elevation of insulin levels and activation of the sympathetic system. |
BACKGROUND | We have previously reported , in an uncontrolled trial , an improvement in fatigue scores in patients with primary biliary cirrhosis given oral antioxidant supplementation . | We have previously reported, in an uncontrolled trial, an improvement in fatigue scores in patients with primary biliary cirrhosis given oral antioxidant supplementation. |
BACKGROUND | We now present data from a controlled trial . | We now present data from a controlled trial. |
METHODS | Sixty-one patients with primary biliary cirrhosis-associated fatigue were randomized into a double-blind , placebo-controlled , cross-over trial . | Sixty-one patients with primary biliary cirrhosis-associated fatigue were randomized into a double-blind, placebo-controlled, cross-over trial. |
METHODS | Participants received 12 weeks each of placebo and antioxidant supplementation ( vitamins A , C and E , selenium , methionine and ubiquinone ) in random order , separated by a 4-week washout period . | Participants received 12 weeks each of placebo and antioxidant supplementation (vitamins A, C and E, selenium, methionine and ubiquinone) in random order, separated by a 4-week washout period. |
METHODS | The primary trial outcome ( fatigue ) was assessed using the Fisk scale . | The primary trial outcome (fatigue) was assessed using the Fisk scale. |
METHODS | Other symptoms of primary biliary cirrhosis were measured using Likert and visual analogue scales . | Other symptoms of primary biliary cirrhosis were measured using Likert and visual analogue scales. |
RESULTS | Forty-four patients completed both arms of the trial . | Forty-four patients completed both arms of the trial. |
RESULTS | No significant changes in fatigue were recorded in the active phase of treatment ( median improvement in Fisk score , 1 ; P = 0.61 ) . | No significant changes in fatigue were recorded in the active phase of treatment (median improvement in Fisk score, 1 ; P = 0. 61). |
RESULTS | Small improvements in Fisk scores were recorded during placebo therapy ( median improvement , 4 ; P = 0.03 ) . | Small improvements in Fisk scores were recorded during placebo therapy (median improvement, 4 ; P = 0. 03). |
RESULTS | Neither medication was associated with improvement in any other symptoms related to primary biliary cirrhosis . | Neither medication was associated with improvement in any other symptoms related to primary biliary cirrhosis. |
RESULTS | Adverse effects were more common during active therapy and were mild and self-limiting . | Adverse effects were more common during active therapy and were mild and self-limiting. |
RESULTS | One patient died from unrelated causes during active treatment . | One patient died from unrelated causes during active treatment. |
CONCLUSIONS | Although oral antioxidant supplementation appears to be safe , we could not find any evidence for a beneficial effect on fatigue or other liver-related symptoms . | Although oral antioxidant supplementation appears to be safe, we could not find any evidence for a beneficial effect on fatigue or other liver-related symptoms. |
OBJECTIVE | To compare a simplified method of measuring extravascular lung water ( EVLW ) using only a single indicator ( EVLW-SI ) with the standard double indicator dilution technique ( EVLW-DI ) . | To compare a simplified method of measuring extravascular lung water (EVLW) using only a single indicator (EVLW-SI) with the standard double indicator dilution technique (EVLW-DI). |
METHODS | Direct comparison of EVLW-SI with EVLW-DI in 18 critically ill patients . | Direct comparison of EVLW-SI with EVLW-DI in 18 critically ill patients. |
METHODS | A general medical ICU in a university-affiliated hospital . | A general medical ICU in a university-affiliated hospital. |
METHODS | Nine men and nine women , ages 19 to 80 yr . | Nine men and nine women, ages 19 to 80 yr. |
METHODS | Six patients were in shock ( four from septic shock ) , and 11 were in respiratory failure . | Six patients were in shock (four from septic shock), and 11 were in respiratory failure. |
METHODS | EVLW-DI and cardiac output were measured in triplicate during injection of cold indocyanine green dye . | EVLW-DI and cardiac output were measured in triplicate during injection of cold indocyanine green dye. |
METHODS | Cardiac output was calculated both from pulmonary artery ( COpa ) and femoral artery ( COfem-di ) thermal dilution signals . | Cardiac output was calculated both from pulmonary artery (COpa) and femoral artery (COfem-di) thermal dilution signals. |
METHODS | EVLW-SI and COfem-si were also measured during three additional injections of cold saline using only thermal signals from the pulmonary and femoral arteries . | EVLW-SI and COfem-si were also measured during three additional injections of cold saline using only thermal signals from the pulmonary and femoral arteries. |
METHODS | Order of measurements was random . | Order of measurements was random. |
METHODS | EVLW-SI was measured in ten patients while blood was withdrawn through the femoral catheter and in ten patients without blood drawn through the femoral catheter . | EVLW-SI was measured in ten patients while blood was withdrawn through the femoral catheter and in ten patients without blood drawn through the femoral catheter. |
RESULTS | A total of 84 comparisons were made . | A total of 84 comparisons were made. |
RESULTS | Although the overall correlations were good ( r2 = .86 ) , EVLW-SI systematically overestimated EVLW-DI ( p less than .05 ) . | Although the overall correlations were good (r2 =. 86), EVLW-SI systematically overestimated EVLW-DI (p less than. 05). |
RESULTS | This difference was greater when EVLW-SI was measured without blood withdrawal through the femoral catheter . | This difference was greater when EVLW-SI was measured without blood withdrawal through the femoral catheter. |
RESULTS | In this subgroup , mean values for EVLW by the two methods were within 20 % of one another in only two of ten patients , in contrast to the results in six of eight patients in which blood was withdrawn through the catheter . | In this subgroup, mean values for EVLW by the two methods were within 20 % of one another in only two of ten patients, in contrast to the results in six of eight patients in which blood was withdrawn through the catheter. |
RESULTS | COfem-si and COfem-di also overestimated COpa . | COfem-si and COfem-di also overestimated COpa. |
CONCLUSIONS | Theoretically , neither injection of green dye nor blood withdrawal should be necessary during measurements of EVLW-SI , making it a simpler technique for bedside use than EVLW-DI . | Theoretically, neither injection of green dye nor blood withdrawal should be necessary during measurements of EVLW-SI, making it a simpler technique for bedside use than EVLW-DI. |
CONCLUSIONS | However , significant discrepancies exist between the two techniques . | However, significant discrepancies exist between the two techniques. |
CONCLUSIONS | Some of this difference is apparently due to technical factors related to catheter design . | Some of this difference is apparently due to technical factors related to catheter design. |
CONCLUSIONS | In any case , we can not recommend use of the single indicator dilution technique at present to estimate EVLW . | In any case, we can not recommend use of the single indicator dilution technique at present to estimate EVLW. |
OBJECTIVE | The dose-effect relationship of nifuratel ( CAS 4936-47-4 ) + nystatin ( CAS 1400-61-9 , CAS 34786-70-4 ) ( Macmiror Complex ) in topical treatment of vulvo-vaginitis was studied . | The dose-effect relationship of nifuratel (CAS 4936-47-4) + nystatin (CAS 1400-61-9, CAS 34786-70-4) (Macmiror Complex) in topical treatment of vulvo-vaginitis was studied. |
METHODS | Sixty patients with Trichomoniasis and/or Candidiasis were randomized to : 1 ) nifuratel 125 mg/nystatin 50000 IU , 2 ) nifuratel 250 mg/nystatin 100000 IU , 3 ) nifuratel 500 mg/nystatin 200000 IU . | Sixty patients with Trichomoniasis and/or Candidiasis were randomized to : 1) nifuratel 125 mg/nystatin 50000 IU, 2) nifuratel 250 mg/nystatin 100000 IU, 3) nifuratel 500 mg/nystatin 200000 IU. |
METHODS | Undistinguishable ovules were intravaginally applied qd for 10 days . | Undistinguishable ovules were intravaginally applied qd for 10 days. |
METHODS | The dose-effect relationship was assessed by ANCOVA . | The dose-effect relationship was assessed by ANCOVA. |
RESULTS | After 5 days the microbiological cure rate occurred in 10 % of patients in the least dose , in 40 % in the middle dose and in 85 % in the highest dose group ( P = 0.000 ) . | After 5 days the microbiological cure rate occurred in 10 % of patients in the least dose, in 40 % in the middle dose and in 85 % in the highest dose group (P = 0. 000). |
RESULTS | After 10 days of treatment , the microbiological cure rate increased to 45 % , 84 % , and 95 % , respectively ( P = 0.007 ) . | After 10 days of treatment, the microbiological cure rate increased to 45 %, 84 %, and 95 %, respectively (P = 0. 007). |
RESULTS | Clinical signs and symptoms gradually disappeared in a dose - and time-dependent manner . | Clinical signs and symptoms gradually disappeared in a dose - and time-dependent manner. |
RESULTS | No relapse has been observed after 10 day-follow up on 46 patients . | No relapse has been observed after 10 day-follow up on 46 patients. |
CONCLUSIONS | The results confirmed a linear relationship between nifuratel + nystatin dose and effect . | The results confirmed a linear relationship between nifuratel + nystatin dose and effect. |
CONCLUSIONS | The least effective dose was nifuratel 250 mg + nystatin 100,000 IU once daily for 5 days and the best dose in terms of risk/benefit ratio was nifuratel 500 mg + nystatin 200,000 IU once daily for 5 days . | The least effective dose was nifuratel 250 mg + nystatin 100, 000 IU once daily for 5 days and the best dose in terms of risk/benefit ratio was nifuratel 500 mg + nystatin 200, 000 IU once daily for 5 days. |
BACKGROUND | Surgical Site Infection ( SSI ) is the third most frequent nosocomial infection , and accounts for 14-16 % of all infections . | Surgical Site Infection (SSI) is the third most frequent nosocomial infection, and accounts for 14-16 % of all infections. |
BACKGROUND | While the treatment of SSI can be very costly , previous results indicated that triclosan may reduce SSI rate . | While the treatment of SSI can be very costly, previous results indicated that triclosan may reduce SSI rate. |
BACKGROUND | Therefore , we carried out a prospective randomised trial to further evaluate the effect of triclosan after elective colorectal surgery . | Therefore, we carried out a prospective randomised trial to further evaluate the effect of triclosan after elective colorectal surgery. |
METHODS | Seven surgical units in Hungary were involved in a prospective , randomised , multicentric clinical trial to compare triclosan coated ( PDS plus ) and uncoated ( PDS II ) sutures for abdominal wall closure in elective colorectal surgery . | Seven surgical units in Hungary were involved in a prospective, randomised, multicentric clinical trial to compare triclosan coated (PDS plus) and uncoated (PDS II) sutures for abdominal wall closure in elective colorectal surgery. |
METHODS | Pre - and perioperative variables were recorded in an online database . | Pre - and perioperative variables were recorded in an online database. |
METHODS | The primary aims of the study were to determine the incidence of SSI and the pathogens associated with it , as well as evaluation of additional cost of treatment . | The primary aims of the study were to determine the incidence of SSI and the pathogens associated with it, as well as evaluation of additional cost of treatment. |
RESULTS | 485 patients were randomised . | 485 patients were randomised. |
RESULTS | SSI occurred in 47 cases ( 12.5 % ) , of those 23 ( 12.23 % ) from the triclosan group ( n = 188 ) and 24 ( 12.18 % ) from the uncoated group ( n = 197 , p = 0.982 ) . | SSI occurred in 47 cases (12. 5 %), of those 23 (12. 23 %) from the triclosan group (n = 188) and 24 (12. 18 %) from the uncoated group (n = 197, p = 0. 982). |
RESULTS | In 13 ( 27.66 % ) cases late appearance of SSI was detected , of those 4 patients with triclosan coated suture ( 8.51 % ) and 9 patients with uncoated suture ( 19.15 % , p = 0.041 ) . | In 13 (27. 66 %) cases late appearance of SSI was detected, of those 4 patients with triclosan coated suture (8. 51 %) and 9 patients with uncoated suture (19. 15 %, p = 0. 041). |
RESULTS | There was no difference between the type of incisions or elective colon and rectal resections in terms of incidence of SSI . | There was no difference between the type of incisions or elective colon and rectal resections in terms of incidence of SSI. |
CONCLUSIONS | Beneficial effect of triclosan against Gram positive bacteria could not be confirmed in our study due to the relatively low number of patients with SSI . | Beneficial effect of triclosan against Gram positive bacteria could not be confirmed in our study due to the relatively low number of patients with SSI. |
CONCLUSIONS | Furthermore , triclosan did not influence the incidence of SSI due to Gram negative bacteria . | Furthermore, triclosan did not influence the incidence of SSI due to Gram negative bacteria. |
CONCLUSIONS | SSI rate decreased by 50 % compared to our previous study , however , it was regardless of the use of coated or uncoated PDS loop . | SSI rate decreased by 50 % compared to our previous study, however, it was regardless of the use of coated or uncoated PDS loop. |
CONCLUSIONS | Finally , operative factors were more important than patient 's risk factors in terms of incidence of SSI . | Finally, operative factors were more important than patient 's risk factors in terms of incidence of SSI. |
CONCLUSIONS | In case SSI developed , delayed discharge from hospital as well as special wound care significantly increased overall cost of treatment . | In case SSI developed, delayed discharge from hospital as well as special wound care significantly increased overall cost of treatment. |
OBJECTIVE | This article provides new data on a controversial issue , the influence of doses on the diffusion characteristics of 2 botulinum toxins type A. OBJECTIVE To assess the fields of effect of abobotulinumtoxinA and onabotulinumtoxinA at the same labeled unit dose ( 1:1 U ) comparing sweat gland and muscle activity . | This article provides new data on a controversial issue, the influence of doses on the diffusion characteristics of 2 botulinum toxins type A. OBJECTIVE To assess the fields of effect of abobotulinumtoxinA and onabotulinumtoxinA at the same labeled unit dose (1:1 U) comparing sweat gland and muscle activity. |